Alnylam Pharmaceuticals
ALNY
#546
Rank
โ‚ฌ37.84 B
Marketcap
283,65ย โ‚ฌ
Share price
3.38%
Change (1 day)
34.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report